These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1893641)

  • 1. ACE inhibitors in renal disease.
    Bauer JH; Reams GP
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV38-43; discussion IV51-5. PubMed ID: 1893641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension with co-existing renal disease.
    Bauer JH; Reams GP
    J Hum Hypertens; 1990 Dec; 4 Suppl 5():27-34. PubMed ID: 2090835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ACE inhibitors and the kidney].
    Hörl WH
    Wien Med Wochenschr; 1996; 146(11):231-4; discussion 234-5. PubMed ID: 8928521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
    Guidi E; Minetti EE; Cozzi MG
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):40-5. PubMed ID: 11984747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors in chronic renal failure.
    Opsahl JA; Abraham PA; Keane WF
    Drugs; 1990; 39 Suppl 2():23-32. PubMed ID: 2188823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ACE inhibition on renal haemodynamics in essential hypertension and hypertension associated with chronic renal failure.
    Sánchez RA; Traballi CA; Marcó EJ; Gilbert BH; Ramírez AJ; Long G
    Drugs; 1991; 41 Suppl 1():25-30. PubMed ID: 1712268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic strategy for progressive renal disease].
    Hayashi K; Ozawa Y; Tokuyama H
    Nihon Rinsho; 2001 May; 59(5):955-60. PubMed ID: 11391998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the renal microcirculation in antihypertensive therapy.
    Inman SR; Stowe NT; Vidt DG
    Cleve Clin J Med; 1994; 61(5):356-62. PubMed ID: 7955308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibitors and progression of chronic renal failure.
    Tolins JP; Raij L
    Kidney Int Suppl; 1990 Nov; 30():S118-22. PubMed ID: 2259070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long- versus short-term effects of two different ACE inhibitors on renal haemodynamics: preliminary results from an ongoing trial.
    Minetti EE; Cozzi MG; Guidi E
    Nephrol Dial Transplant; 1995; 10 Suppl 6():18-21. PubMed ID: 8524487
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal effects of converting enzyme inhibitors in hypertension and diabetes.
    Anderson S
    J Cardiovasc Pharmacol; 1990; 15 Suppl 3():S11-5. PubMed ID: 1691412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ACE inhibitors in kidney diseases--only another antihypertensive agent?].
    Ritz E; Stein G
    Med Klin (Munich); 1994 Sep; 89(9):473-5. PubMed ID: 7968882
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic benefit of converting-enzyme inhibition in progressive renal disease.
    Anderson S; Brenner BM
    Am J Hypertens; 1988 Oct; 1(4 Pt 2):380S-383S. PubMed ID: 3056448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic implications of converting-enzyme inhibitors in renal disease.
    Anderson S; Brenner BM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):81-7. PubMed ID: 3037894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
    Barnas U; Mayer G
    Wien Klin Wochenschr; 1995; 107(1):10-4. PubMed ID: 7871784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of antihypertensive agents in parenchymal renal disease and renovascular hypertension.
    Mimran A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S45-50. PubMed ID: 1382165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
    van Essen GG; Apperloo AJ; Rensma PL; Stegeman CA; Sluiter WJ; de Zeeuw D; de Jong PE
    Kidney Int Suppl; 1997 Dec; 63():S58-62. PubMed ID: 9407423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes.
    Cherney DZ; Sochett EB; Miller JA
    Kidney Int; 2005 Oct; 68(4):1722-8. PubMed ID: 16164648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.